FDA Inspection
Norwich Pharmaceuticals, Inc.Norwich Pharmaceuticals, Inc. – FDA Inspection, Dec 22, 2010
Record Details
This FDA Inspection record concerns Norwich Pharmaceuticals, Inc., with an inspection on December 22, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- December 22, 2010
- Product Type
- Drugs
View Company Profile
ID · ea7c3d84-cf1b-4666-a7ba-5885778afd1a
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 703071
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Norwich Pharmaceuticals, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| December 17, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 16, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 9, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 23, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 12, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Norwich Pharmaceuticals, Inc.
- FDA Inspection 1298640 - 2025-12-17
- FDA Inspection 1136679 - 2021-03-16
- FDA Inspection 1043457 - 2018-02-09
- FDA Inspection 950656 - 2015-10-23
- FDA Inspection 840195 - 2013-07-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.